Clinical Trial

A Well-Being Intervention for People With IBS

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this randomized behavioral clinical trial is to examine whether a well-being intervention can improve both psychological well-being and physical outcomes in adults with Irritable Bowel Syndrome (IBS). The study aims to assess whether this intervention decreases anger, anxiety, and depression; increases self-esteem, empathy, and hope; and improves quality of life indicators such as IBS symptom severity, sleep quality, fatigue, and diet. Participants can expect to be on study for up to 9 months.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-13.
Trial Details
NCT Number NCT07600047
Lead Sponsor University of Wisconsin, Madison
Conditions Irritable Bowel Syndrome
Enrollment 150 participants
Start Date 2026-09
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-08-13